Chronic kidney disease among US adults with type 2 diabetes and cardiovascular diseases: A national estimate of prevalence by KDIGO 2012 classification
| Autor: | Hakima Hannanchi, Tongtong Wang, Carol E. Koro, Robert Lubwama, Yuzhi Xi, Kristy Iglay |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Adult
Male medicine.medical_specialty endocrine system diseases Adolescent Endocrinology Diabetes and Metabolism medicine.medical_treatment Type 2 diabetes 030204 cardiovascular system & hematology Angina 03 medical and health sciences Young Adult 0302 clinical medicine Diabetes mellitus Internal medicine Internal Medicine medicine Prevalence Humans 030212 general & internal medicine Renal Insufficiency Chronic Stroke Aged High prevalence business.industry Insulin nutritional and metabolic diseases General Medicine Middle Aged medicine.disease Nutrition Surveys United States Cross-Sectional Studies Diabetes Mellitus Type 2 Cardiovascular Diseases Heart failure Female business Kidney disease Glomerular Filtration Rate |
| Zdroj: | Diabetesmetabolic syndrome. 13(1) |
| ISSN: | 1878-0334 |
| Popis: | Aim Data on prevalence of chronic kidney disease (CKD) among US adults with type 2 diabetes (T2D) and cardiovascular diseases (CVD) are limited. The aim of this study was to provide such estimates for T2D, both overall and in those with CVD. Materials and methods Using the NHANES 2007–2014 data, we conducted a cross-sectional analysis of an adult sample with diagnosed and undiagnosed T2D, aged ≥18 years. CVD was defined based on self-reported personal interview data on a broad range of health conditions—congestive heart failure, coronary heart disease, angina, stroke, or heart attack. T2D was defined as diagnosed T2D (self-reported provider diagnosis) and undiagnosed T2D (FPG ≥126 mg/dL or HbA1c ≥ 6.5% without self-reported diagnosis). Participants who started insulin within a year of T2D diagnosis, or were pregnant at the time of health examination were excluded. Appropriate sample weights were used to provide a national estimate. Results The prevalence of moderate to severe renal impairment based on eGFR below 60 ml/min/1.73 m2 among T2D was 18.0%. The prevalence of mild renal impairment was 36.9%: 28.3% with UACR 300 mg/g. For T2D and CVD subgroup, the prevalence was 33.6% for moderate to severe renal impairment and 42.8% for mild renal impairment. Conclusions This study confirms the high prevalence of CKD in patients with multiple comorbidities: T2D and CVD. It also provides estimates of the prevalence of CKD categories based on KDIGO 2012 classification for US adults with T2D. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect